onasemnogene abeparvovec

Summary

onasemnogene abeparvovec is a medication^[1]. It draws 97 Wikipedia views per month (medication category, ranking #48 of 213).^[2]

Key Facts

• onasemnogene abeparvovec's instance of is recorded as medication^[3].
• onasemnogene abeparvovec's instance of is recorded as gene therapy^[4].
• onasemnogene abeparvovec's manufacturer is recorded as Novartis^[5].
• onasemnogene abeparvovec's CAS Registry Number is recorded as 1922968-73-7^[6].
• onasemnogene abeparvovec's route of administration is recorded as intravenous administration^[7].
• onasemnogene abeparvovec's PubChem CID is recorded as 381128165^[8].
• onasemnogene abeparvovec's KEGG ID is recorded as D11559^[9].
• onasemnogene abeparvovec's DrugBank ID is recorded as DB15528^[10].
• onasemnogene abeparvovec's Google Knowledge Graph ID is recorded as /g/11fd6dcygv^[11].
• onasemnogene abeparvovec's legal status is recorded as boxed warning^[12].
• onasemnogene abeparvovec's UK Parliament thesaurus ID is recorded as 489444^[13].
• onasemnogene abeparvovec's PBS Drug Code is recorded as 12964H^[14].
• onasemnogene abeparvovec's WikiProjectMed ID is recorded as Onasemnogene abeparvovec^[15].

Why It Matters

onasemnogene abeparvovec draws 97 Wikipedia views per month (medication category, ranking #48 of 213).^[2] It has Wikipedia articles in 17 language editions, a strong signal of global cultural recognition.^[16] It is known by 8 alternative names across languages and contexts.^[17]